medicine

Amgen and Astellas announce Japan Alliance Amgen.

‘With Astellas’ strong capabilities and excellent reputation, this alliance will help accelerate development and commercialization of Amgen medicines for patients in Japan. This alliance displays our long-term commitment to the Japan market and can be an important part of our global expansion efforts.’ ‘We look forward to getting into this alliance with Amgen and believe it will strengthen our pipeline to handle unmet medical needs, as well as enable us to obtain growth drivers,’ said Yoshihiko Hatanaka, cEO and president of Astellas. ‘We will work carefully with Amgen to build the jv, which will provide innovative medications to patients in Japan.’ Goldman, Sachs & Co. Continue reading

CMS delays Florida MLR decision.

CMS delays Florida MLR decision; Conn. Exchange table under fire In Florida and Connecticut, officials are wrestling with issues linked to implementation of the nationwide health reform legislation. CQ HealthBeat: And The Florida MLR Waiver Decision Is usually vardenafilcanadian.com/levitra-faq.html . Not Ready Centers for Medicare and Medicaid Solutions officials have provided themselves 30 more days to decide on Florida’s demand to slow the phase-in of a requirement that insurers spend at the least 80 % of each premium dollar on expenses related to improving the quality of health care . Related StoriesTissue Regenix strengthens placement in post-acute wound care market with Medicare insurance for DermapureACA launches nationwide effort to eliminate anti-competitive provision of Medicare lawYale researchers find improvements in mortality, hospitalizations and outcomes among Medicare patientsThe Connecticut Mirror: Critics Seek Ethics Inquiry Into Exchange Panel Eight groups have got signed a letter asking the Office of Condition Ethics to consider what they say are possible conflicts of interest among associates of the board that oversees the state’s medical health insurance exchange. Continue reading